Seamus Sreenan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Seamus Sreenan has a total of 95 co-authors. Here are the top co-authors by number of shared publications:
John H. McDermott
Academic Dept of Endocrinology and Diabetes, Royal College of Surgeons in Ireland, Connolly Hospital, Blanchardstown, Dublin, Ireland
4 shared publications- Tommy Kyaw Tun
Department of Medicine, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, 123 St Stephens Green, D02 YN77 Dublin, Ireland
4 shared publications - Diarmuid Smith
Endocrinology Department, Beaumont Hospital, Dublin, Ireland
3 shared publications - Frank Doyle
RCSI University of Medicine and Health Sciences, Dublin, Ireland
3 shared publications - Katarzyna Anna Gajewska
Diabetes Ireland, Dublin, Ireland
3 shared publications - Kathleen Bennett
Data Science Centre, School of Population Health, RCSI University of Medicine and Health Sciences, Dublin, Ireland
3 shared publications
Latest Publications
- Open Access
- 19 September 2026
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 241
Review of the relationship between deficiency of Glucose-6-phosphate dehydrogenase deficiency and diabetes and its complications
- 19 September 2026
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 241
Open AccessReview of the relationship between deficiency of Glucose-6-phosphate dehydrogenase deficiency and diabetes and its complications
- Open Access
- 20 August 2026
- Published by Wiley in Journal of Diabetes Investigation
- Vol. 17 (11) , 2009-2018
Evaluating the effectiveness and acceptability of an animated educational tool for diabetic foot care: A randomized controlled trial and mixed‐methods study in patients with active, in‐remission and high‐risk diabetic foot disease
Introduction: Patients with diabetes have a 2% annual risk of developing a Diabetic Foot Ulcer (DFU). Novel methods of reducing the risk of re‐ulceration could reduce the cost of diabetic foot disease. Materials and Methods: Fifty‐two patients with active foot disease, a history of prior DFU and/or high‐risk feet were included in this study. Patients were randomly assigned 50:50 to be educated conventionally by a podiatrist or to view a bespoke foot self‐care educational animation developed by the research team for this exploratory pilot study. A modified Nottingham Assessment of Functional Footcare (NAFF) questionnaire was used to record knowledge of safe foot care behaviors pre‐ and post‐intervention. The primary outcome was change in self‐care knowledge score. In parallel, a mixed‐methods acceptability study was carried out for the 26 patients in the intervention arm, with quantitative data obtained using a 20‐item technology acceptance model. Qualitative data were obtained by face‐to‐face interviews in the clinic setting and examined using thematic analysis. Results: While foot self‐care knowledge scores were numerically higher in both groups, only the intervention group showed a statistically significant within‐group improvement. There was a trend toward a greater magnitude of increase in the knowledge score in favor of the intervention group, but this did not reach statistical significance. Among the 26 patients who completed the technology acceptability study, the majority of responses were in favor of the educational video. Conclusions: This randomized controlled and mixed‐methods study demonstrated positive results in terms of improvements in foot self‐care knowledge and acceptability.
- 20 August 2026
- Published by Wiley in Journal of Diabetes Investigation
- Vol. 17 (11) , 2009-2018
Open AccessEvaluating the effectiveness and acceptability of an animated educational tool for diabetic foot care: A randomized controlled trial and mixed‐methods study in patients with active, in‐remission and high‐risk diabetic foot disease
Introduction: Patients with diabetes have a 2% annual risk of developing a Diabetic Foot Ulcer (DFU). Novel methods of reducing the risk of re‐ulceration could reduce the cost of diabetic foot disease. Materials and Methods: Fifty‐two patients with active foot disease, a history of prior DFU and/or high‐risk feet were included in this study. Patients were randomly assigned 50:50 to be educated conventionally by a podiatrist or to view a bespoke foot self‐care educational animation developed by the research team for this exploratory pilot study. A modified Nottingham Assessment of Functional Footcare (NAFF) questionnaire was used to record knowledge of safe foot care behaviors pre‐ and post‐intervention. The primary outcome was change in self‐care knowledge score. In parallel, a mixed‐methods acceptability study was carried out for the 26 patients in the intervention arm, with quantitative data obtained using a 20‐item technology acceptance model. Qualitative data were obtained by face‐to‐face interviews in the clinic setting and examined using thematic analysis. Results: While foot self‐care knowledge scores were numerically higher in both groups, only the intervention group showed a statistically significant within‐group improvement. There was a trend toward a greater magnitude of increase in the knowledge score in favor of the intervention group, but this did not reach statistical significance. Among the 26 patients who completed the technology acceptability study, the majority of responses were in favor of the educational video. Conclusions: This randomized controlled and mixed‐methods study demonstrated positive results in terms of improvements in foot self‐care knowledge and acceptability.
- Open Access
- 22 May 2026
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 195 (5) , 3269-3270
Correction: Blood glucose testing modalities utilized by people with type 2 diabetes in a secondary care setting
- 22 May 2026
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 195 (5) , 3269-3270
Open AccessCorrection: Blood glucose testing modalities utilized by people with type 2 diabetes in a secondary care setting
- Open Access
Biomarkers to predict outcomes in diabetic foot ulcers
Diabetic Foot Ulcers (DFUs) are among the most feared complications of diabetes mellitus (DM). The management of DFUs emphasizes limb salvage, and to achieve this, clinical tools are utilized to identify patients who may require a more aggressive initial approach. Current clinical prediction models fail to account for variability in ulcer characteristics and patient‐specific comorbidities, limiting their precision in individualizing outcome prediction. This review explores the emerging role of molecular biomarkers in personalizing DFU outcome prediction. The pathophysiology of DFUs is examined with an emphasis on disruptions in wound healing specific to DM, focusing on biomarkers involved at different stages of wound healing. This review highlights studies that have shown predictive potential of several biomarkers in a variety of biological samples from patients with DFUs. Despite promising findings, challenges remain in their clinical adoption. Larger studies and the development of accessible, biomarker‐based diagnostics are essential to translate this approach into clinical settings and ultimately reduce the global burden of DFUs through personalized therapy, which would considerably increase the quality of life of people with DM.
Open AccessBiomarkers to predict outcomes in diabetic foot ulcers
Diabetic Foot Ulcers (DFUs) are among the most feared complications of diabetes mellitus (DM). The management of DFUs emphasizes limb salvage, and to achieve this, clinical tools are utilized to identify patients who may require a more aggressive initial approach. Current clinical prediction models fail to account for variability in ulcer characteristics and patient‐specific comorbidities, limiting their precision in individualizing outcome prediction. This review explores the emerging role of molecular biomarkers in personalizing DFU outcome prediction. The pathophysiology of DFUs is examined with an emphasis on disruptions in wound healing specific to DM, focusing on biomarkers involved at different stages of wound healing. This review highlights studies that have shown predictive potential of several biomarkers in a variety of biological samples from patients with DFUs. Despite promising findings, challenges remain in their clinical adoption. Larger studies and the development of accessible, biomarker‐based diagnostics are essential to translate this approach into clinical settings and ultimately reduce the global burden of DFUs through personalized therapy, which would considerably increase the quality of life of people with DM.
- Open Access
- 24 April 2026
- Published by MDPI AG in Biomolecules
- Vol. 16 (5) , 634
Headspace Volatile Organic Compound (VOC) Profiling of Infected and Non-Infected Wound Swabs—A Pilot Study
Infections of chronic wounds are a major healthcare burden worldwide and can lead to poor health outcomes such as amputations of limbs and death. Detecting infections early significantly increases the effectiveness of therapeutic interventions. Screening of volatile organic compounds (VOCs) emitted from wound swab samples can potentially serve as a highly specific indicator of infection. Profiling of VOCs from infected and non-infected wounds was carried out. Swab samples were collected from 26 wounds from 23 patients (n = 20 diabetic patients; n = 3 non-diabetic patients). There were 16 wounds sampled that were clinically determined as infected, and 10 as non-infected. Headspace-solid phase microextraction gas chromatography-mass spectrometry (HS-GC-MS) was used to rapidly sample and detect VOCs from the swabs following a short incubation period. A total of 42 compounds were identified and included for analysis. Infected wounds emitted more diverse VOCs compared to non-infected wounds. Higher numbers of compounds with significantly higher abundances were detected from severely infected wounds compared to less severely infected wounds. Abundances of short-chain fatty acids (SCFAs) and branched-chain fatty acids (BCFAs) were found to be the strongest discriminators of infected from non-infected wounds. Further validation is needed, but the results of this pilot study highlight the potential of detecting these compounds as a highly specific and targeted route to predicting or detecting wound infections in the future.
- 24 April 2026
- Published by MDPI AG in Biomolecules
- Vol. 16 (5) , 634
Open AccessHeadspace Volatile Organic Compound (VOC) Profiling of Infected and Non-Infected Wound Swabs—A Pilot Study
Infections of chronic wounds are a major healthcare burden worldwide and can lead to poor health outcomes such as amputations of limbs and death. Detecting infections early significantly increases the effectiveness of therapeutic interventions. Screening of volatile organic compounds (VOCs) emitted from wound swab samples can potentially serve as a highly specific indicator of infection. Profiling of VOCs from infected and non-infected wounds was carried out. Swab samples were collected from 26 wounds from 23 patients (n = 20 diabetic patients; n = 3 non-diabetic patients). There were 16 wounds sampled that were clinically determined as infected, and 10 as non-infected. Headspace-solid phase microextraction gas chromatography-mass spectrometry (HS-GC-MS) was used to rapidly sample and detect VOCs from the swabs following a short incubation period. A total of 42 compounds were identified and included for analysis. Infected wounds emitted more diverse VOCs compared to non-infected wounds. Higher numbers of compounds with significantly higher abundances were detected from severely infected wounds compared to less severely infected wounds. Abundances of short-chain fatty acids (SCFAs) and branched-chain fatty acids (BCFAs) were found to be the strongest discriminators of infected from non-infected wounds. Further validation is needed, but the results of this pilot study highlight the potential of detecting these compounds as a highly specific and targeted route to predicting or detecting wound infections in the future.
- 9 April 2026
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 195 (3) , 1359-1363
Blood glucose testing modalities utilized by people with type 2 diabetes in a secondary care setting
- 9 April 2026
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 195 (3) , 1359-1363
Blood glucose testing modalities utilized by people with type 2 diabetes in a secondary care setting
- Open Access
Evaluating the effectiveness of the D1 Now intervention to improve outcomes among young adults with type 1 diabetes: Protocol for a cluster randomised controlled trial
Background: Young adults living with type 1 diabetes (T1D) often experience sub-optimal outcomes due to competing life demands, disruptions in care, reduced clinic attendance, and difficulties in self-management. To improve outcomes among this population, we developed and piloted the D1 Now intervention using a user-centred and theory-informed approach. This protocol describes a cluster randomised controlled trial (RCT) to test the effectiveness and cost-effectiveness of the D1 Now intervention. Methods: A cluster RCT seeking to recruit 348 young adults (aged 18–25) with T1D from 12 hospital diabetes centres in Ireland. Centres will be randomised to receive either standard care or the D1 Now intervention, which includes two components: an agenda-setting tool and a support worker. The primary outcome is the change in HbA1c from baseline to 12-month follow-up. Secondary outcomes include patient-reported psychosocial outcomes, clinical outcomes, self-management outcomes and healthcare utilisation. We will collect data through blood samples, online patient surveys, and patient records at baseline and 12 months. Additionally, we will conduct a cost-effectiveness evaluation and a mixed-methods process evaluation. Discussion: We anticipate that the D1 Now intervention will be both effective and cost-effective in improving clinical and psychosocial outcomes for young adults compared to standard care. The findings from the process evaluation will shed light on how the intervention works (or not) and how implementation into health services (if warranted) can be optimised. If effective, D1 Now will offer a sustainable model of care to support engagement and self-management for young adults living with T1D. Trial registration: ISRCTN Identifier: ISRCTN28944606 . Date applied 01 May 2025
Open AccessEvaluating the effectiveness of the D1 Now intervention to improve outcomes among young adults with type 1 diabetes: Protocol for a cluster randomised controlled trial
Background: Young adults living with type 1 diabetes (T1D) often experience sub-optimal outcomes due to competing life demands, disruptions in care, reduced clinic attendance, and difficulties in self-management. To improve outcomes among this population, we developed and piloted the D1 Now intervention using a user-centred and theory-informed approach. This protocol describes a cluster randomised controlled trial (RCT) to test the effectiveness and cost-effectiveness of the D1 Now intervention. Methods: A cluster RCT seeking to recruit 348 young adults (aged 18–25) with T1D from 12 hospital diabetes centres in Ireland. Centres will be randomised to receive either standard care or the D1 Now intervention, which includes two components: an agenda-setting tool and a support worker. The primary outcome is the change in HbA1c from baseline to 12-month follow-up. Secondary outcomes include patient-reported psychosocial outcomes, clinical outcomes, self-management outcomes and healthcare utilisation. We will collect data through blood samples, online patient surveys, and patient records at baseline and 12 months. Additionally, we will conduct a cost-effectiveness evaluation and a mixed-methods process evaluation. Discussion: We anticipate that the D1 Now intervention will be both effective and cost-effective in improving clinical and psychosocial outcomes for young adults compared to standard care. The findings from the process evaluation will shed light on how the intervention works (or not) and how implementation into health services (if warranted) can be optimised. If effective, D1 Now will offer a sustainable model of care to support engagement and self-management for young adults living with T1D. Trial registration: ISRCTN Identifier: ISRCTN28944606 . Date applied 01 May 2025
- 14 October 2025
- Published by Springer Nature in Journal of Diabetes & Metabolic Disorders
- Vol. 24 (2) , 1-9
Comfort matters: evaluating preferences for Non-Invasive diabetes testing over conventional blood tests
Objective Evaluating comfort during traditional Diabetes Mellitus (DM) testing through blood collection versus non-invasive methods among individuals with and without DM and identifying personal characteristics influencing distress. Methods This cross-sectional, observational study included 232 participants whose comfort levels were assessed using ten Likert scale questions. Participants were evaluated during traditional diabetes screening involving blood drawings and non-invasive screening methods. Anthropometrics, demographics, medical history, and HbA1c were also recorded. Principal Component Analysis (PCA) was used to identify factors contributing to participant comfort during traditional and non-invasive diabetes testing. Results Two factors accounted for 57.59% of the variation, χ2(n = 232) = 917.55 (p < 0.001). Six questions were assigned to the Medical Testing Comfort (MTC) factor with a Cronbach’s alpha of 0.876. The MTC questions assessed comfort during the typical diabetes testing procedures available in most developing countries worldwide. Lower MTC scores indicate greater discomfort during conventional tests and a preference for non-invasives. Non-invasive testing was preferred by 84.1 ± 1.5% of all participants, while those without a previous DM diagnosis were three times less likely to choose conventional testing. All children and adults without previous blood test experience preferred non-invasives. Joint mobility measurements were the preferred non-invasive method (98.7 ± 0.5%), followed by skin photography (96.1 ± 0.3%). Conclusions Our findings highlight the importance of patient comfort in diabetes care, emphasizing the preference for non-invasive testing to enhance detection and management. The MTC scale’s findings suggest revising DM testing protocols may expand surveillance, enhance healthcare experiences and improve outcomes.
- 14 October 2025
- Published by Springer Nature in Journal of Diabetes & Metabolic Disorders
- Vol. 24 (2) , 1-9
Comfort matters: evaluating preferences for Non-Invasive diabetes testing over conventional blood tests
Objective Evaluating comfort during traditional Diabetes Mellitus (DM) testing through blood collection versus non-invasive methods among individuals with and without DM and identifying personal characteristics influencing distress. Methods This cross-sectional, observational study included 232 participants whose comfort levels were assessed using ten Likert scale questions. Participants were evaluated during traditional diabetes screening involving blood drawings and non-invasive screening methods. Anthropometrics, demographics, medical history, and HbA1c were also recorded. Principal Component Analysis (PCA) was used to identify factors contributing to participant comfort during traditional and non-invasive diabetes testing. Results Two factors accounted for 57.59% of the variation, χ2(n = 232) = 917.55 (p < 0.001). Six questions were assigned to the Medical Testing Comfort (MTC) factor with a Cronbach’s alpha of 0.876. The MTC questions assessed comfort during the typical diabetes testing procedures available in most developing countries worldwide. Lower MTC scores indicate greater discomfort during conventional tests and a preference for non-invasives. Non-invasive testing was preferred by 84.1 ± 1.5% of all participants, while those without a previous DM diagnosis were three times less likely to choose conventional testing. All children and adults without previous blood test experience preferred non-invasives. Joint mobility measurements were the preferred non-invasive method (98.7 ± 0.5%), followed by skin photography (96.1 ± 0.3%). Conclusions Our findings highlight the importance of patient comfort in diabetes care, emphasizing the preference for non-invasive testing to enhance detection and management. The MTC scale’s findings suggest revising DM testing protocols may expand surveillance, enhance healthcare experiences and improve outcomes.
- Open Access
- 11 July 2024
- Published by Elsevier in Journal of Tissue Viability
- Vol. 33 (4) , 853-863
The impact of machine learning on the prediction of diabetic foot ulcers – A systematic review
- 11 July 2024
- Published by Elsevier in Journal of Tissue Viability
- Vol. 33 (4) , 853-863
Open AccessThe impact of machine learning on the prediction of diabetic foot ulcers – A systematic review
- Open Access
- 14 February 2023
- Published by Taylor & Francis in Medical Education Online
- Vol. 28 (1) , 2176802
The impact of a student-led anti-racism programme on medical students’ perceptions and awareness of racial bias in medicine and confidence to advocate against racism
Systemic racism impacts personal and community health; however, education regarding its role in perpetuating healthcare inequity remains limited in medical curricula. This study implemented and eva...
- 14 February 2023
- Published by Taylor & Francis in Medical Education Online
- Vol. 28 (1) , 2176802
Open AccessThe impact of a student-led anti-racism programme on medical students’ perceptions and awareness of racial bias in medicine and confidence to advocate against racism
Systemic racism impacts personal and community health; however, education regarding its role in perpetuating healthcare inequity remains limited in medical curricula. This study implemented and eva...